Mbx Biosciences Inc (MBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 27,265 | 25,795 | 23,926 | 21,805 | 26,529 |
| Operating Income | -27,265 | -25,795 | -23,926 | -21,805 | -26,529 |
| Other Income | 3,748 | 3,733 | 2,308 | 2,394 | 2,649 |
| Pre-tax Income | -23,517 | -22,062 | -21,618 | -19,411 | -23,880 |
| Net Income Continuous | -23,517 | -22,062 | -21,618 | -19,411 | -23,880 |
| Net Income | $-23,517 | $-22,062 | $-21,618 | $-19,411 | $-23,880 |
| EPS Basic Total Ops | -0.50 | -0.46 | -0.63 | -0.58 | -0.71 |
| EPS Basic Continuous Ops | -0.50 | -0.46 | -0.63 | -0.58 | -0.71 |
| EPS Diluted Total Ops | -0.50 | -0.46 | -0.63 | -0.58 | -0.71 |
| EPS Diluted Continuous Ops | -0.50 | -0.46 | -0.63 | -0.58 | -0.71 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.49 | -0.63 | -0.58 | -0.71 |
| EBITDA(a) | $-27,201 | $-25,735 | $-23,876 | $-21,744 | $-26,452 |